Bacteria with Antibiotic Resistance Mutations Reproduce Faster than Non-mutated Bacteria



By naturalsciencenews.com

A team of researchers has recently discovered that bacteria reproduce rapidly when exposed to antibiotics. This allows the bacterial colony to develop mutations for antibiotic resistance faster, speeding up evolution. The details are in a paper that was just published in the journal Nature Ecology & Evolution.

Antibiotic resistance is a growing problem that can be incredibly harmful to people with bacterial infections. When bacteria develop a resistance to modern drugs, doctors are left with fewer options for treating their patients. In some cases, bacteria become immune to all common antibiotics and these strains are a serious public health risk. Scientists have frequently studied the evolution of antibiotic resistance in an attempt to solve the problem.

Scientists from the University of Exeter utilized funding from the Engineering and Physical Sciences Research Council (EPSRC) to study how Escherichia coli bacteria develop resistance to antibiotics. The E.coli strain used in the study is harmful to humans, causing symptoms such as severe diarrhea and kidney failure. The team exposed the bacteria to doxycycline, one of the most common antibiotics for treating bacterial infections. The E.coli bacteria were exposed for four days while the researchers measured how quickly they developed mutations for doxycycline resistance. As expected, the bacteria quickly developed these types of mutations. However, the researchers noticed something that they didn’t expect; the bacteria containing the mutations were multiplying faster than non-mutated bacteria. They were reproducing so quickly that their population tripled within the four days of antibiotic exposure. This rapid evolution continued even after the researchers stopped dosing the population with the antibiotics.

The research team’s findings show that bacteria are capable of reproducing quickly when they gain antibiotic resistance mutations, even after they’re no longer exposed to the drug. Once they develop these mutations, they can focus their energy on reproduction instead of survival. The authors note that according to their findings, it’s important to begin antibiotic treatments immediately to avoid this rapid evolution.

REFERENCE

Reding-Roman et al. The unconstrained evolution of fast and efficient antibiotic-resistant bacterial genomes. Nature Ecology & Evolution (2017).


Source: http://naturalsciencenews.com/2017/01/30/bacteria-with-antibiotic-resistance-mutations-reproduce-faster-than-non-mutated-bacteria/


cialis türkei apotheke generic viagra canada viagra thee cialis online viagra and leg cramps cialis online effect of viagra on health viagra online usa cialis bieffekter generic viagra why am i getting viagra emails generic cialis para que sirve las pastillas de cialis generic cialis super active viagra uk cialis 20mg online can i buy viagra over the counter nz buy generic viagra tomando viagra pode beber viagra usa

Sunday, June 14, 2026

Celecoxib: The Generic Form Of Celebrex Explained

Celecoxib is the generic name of the medication sold under the brand name Celebrex. Generic medications contain the same active ingredient at the same dose and strength as their brand name counterparts and must meet the same FDA standards for quality, purity, and bioequivalence. The development and approval of generic drugs play an important role in making effective treatments more accessible and affordable for patients. Pain management has evolved toward a multimodal approach that combines different types of analgesics with physical therapies, psychological interventions, and lifestyle modifications. Using multiple medications with different mechanisms of action can provide better pain control at lower doses of each individual drug, reducing the risk of side effects. For chronic conditions, understanding the distinction between nociceptive pain driven by tissue damage and neuropathic pain caused by nerve injury helps guide more effective treatment selection. The pharmacological action of celecoxib is the basis for its use in treating conditions within the category of pain relief medications. Understanding the mechanism by which the active compound produces its therapeutic effects helps patients appreciate why the medication needs to be taken consistently and at the correct dose to achieve the best results. Switching between brand name and generic versions of a medication is generally considered safe when the products are bioequivalent, but patients should inform their doctor if they notice any differences in effect after a formulary change. Some patients with conditions requiring precise drug levels in the blood may be monitored more closely during transitions. For most patients, however, approved generics provide equivalent therapeutic benefit to the brand name product. The https://mednewwsstoday.com/pain-relief/ section on pain relief medications covers both brand name and generic treatment options, giving patients a complete picture of what is available. Cost, insurance coverage, and pharmacy availability are practical factors to discuss with a pharmacist when filling a prescription for celecoxib.

Sunday, June 7, 2026

Dulcolax: Side Effects, Drug Interactions, And Precautions

Every medication carries the potential for side effects, and Dulcolax (bisacodyl) is no exception. Understanding what side effects are possible, which are common versus rare, and what warning signs warrant medical attention allows patients to use the medication safely and confidently. Most people who take Dulcolax as directed tolerate it without major problems, but individual responses vary. The colon's primary role in the digestive process is absorbing water from undigested food matter and moving waste toward the rectum. Constipation occurs when transit through the colon is too slow, allowing excessive water to be absorbed and resulting in hard, compact stool. Contributing factors include inadequate fluid and fiber intake, insufficient physical activity, certain medications including opioids and some antidepressants, and underlying conditions affecting bowel motility. The most frequently reported side effects of bisacodyl are typically mild and often resolve within days to weeks as the body adjusts. Serious side effects occur less frequently but are documented in prescribing information and patient safety guides. Complete side effect information and precautions are listed at https://mednewwsstoday.com/laxatives/dulcolax-bisacodyl/, which serves as a reliable reference for anyone beginning therapy with Dulcolax or monitoring an ongoing treatment. Drug interactions are an important safety consideration for any medication. Dulcolax may interact with other prescription drugs, over-the-counter medications, supplements, or certain foods, affecting how it is metabolized or how effective it is. A pharmacist or doctor can review a patient's full medication list to identify any clinically significant interactions before starting Dulcolax. Patients should also avoid making changes to their medication regimen without first consulting a healthcare professional. More information on medications used in constipation and bowel health and how they compare in terms of safety and efficacy is available through the resource at https://mednewwsstoday.com/laxatives/. Staying informed helps patients participate actively in decisions about their care.

Monday, June 1, 2026

Ranitidine (Zantac) - Acid Reflux - Patient guide - What to expect

Patients reviewing old reflux treatments often ask whether generic reliability and medication consistency mattered when ranitidine was used in prior years. This question is understandable, especially for people who changed pharmacies often or saw tablets with different appearance between refills. Reliable symptom control usually depends on more than label familiarity. Consistent use, accurate instructions, and timely follow-up have major impact, regardless of brand history. For context about historical ranitidine discussions and current reflux-care planning, patients can read ranitidine treatment reference before meeting their clinician. When pharmacy supply changes, tablets may look different because manufacturers use different inactive ingredients, shape, or color. Appearance changes alone do not always mean therapeutic failure, but any new symptom pattern should be reported quickly. Patients can reduce confusion by keeping a medication log with fill date, pharmacy name, dose strength, and symptom trend during each refill cycle. This simple record allows clinicians and pharmacists to identify whether fluctuations are related to adherence gaps, dietary triggers, or potential product-related differences that require closer review. Communication is central during transitions. Patients should ask pharmacists to verify active ingredient, concentration, and dosing directions every time a refill looks unfamiliar. They should also avoid self-adjusting frequency without medical advice, because overuse or inconsistent use can blur the clinical picture. If discomfort persists despite adherence, clinicians may recommend updated therapies and supportive lifestyle measures instead of repeatedly changing products without a coordinated plan. Lifestyle actions improve reliability of any acid-management approach. Eating smaller evening meals, limiting late caffeine, avoiding tobacco exposure, and staying upright after meals can reduce symptom burden. Sleep positioning and weight-management efforts may also contribute to steadier control. When these habits are paired with consistent medication routines, patients often report fewer breakthrough episodes and less anxiety about day-to-day variability. For broader long-term strategies and prevention habits, patients can also use acid reflux support resources and bring a written list of refill and symptom concerns to follow-up visits. Durable reflux management usually comes from consistent routines, accurate refill verification, and early clinician review when symptom patterns shift.